Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

Collaboration to improve process analytical technologies and AAV manufacturing for gene therapies

Expert interview on the use of AI in the ATMP industry

Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim

Rentschler Biopharma

Your partner for high-quality biopharmaceuticals

We are a leading global Contract Development and Manufacturing Organization (CDMO), focused exclusively on client projects. From our headquarters in Laupheim, Germany, and our site in Milford, MA, USA, we offer end-to-end solutions including biopharmaceutical process development and manufacturing as well as related consulting activities such as project management and regulatory support. Thanks to our 50 years of proven scientific expertise in biotechnology and our passion for what we do, we count ourselves among the leaders in the industry and make an essential contribution to the global availability of biopharmaceuticals.

With Rentschler Biopharma, you are in expert hands.

Flexibility

We believe that revolutionary ideas come to life when they have the space to develop.

Clients

The unique feature of our client dialogue is actually quite simple: We are listening.

Solutions

Our secret: We find solutions where others do not even look.

Performance

Our track record: Security for our clients. Guidepost for our future.

Our Services

As a leading CDMO, we develop and manufacture biopharmaceuticals and support you with the creation of approval documents at an international level. We are a specialist for mammalian expression. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler Biopharma’s high quality standards. With our full-service offering, we are your partner of choice.